Raab & Moskowitz Asset Management LLC Pfizer Inc Transaction History

Raab & Moskowitz Asset Management LLC

$393 Million
Q3 2024

A detailed history of Raab & Moskowitz Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 259,134 shares of PFE stock, worth $6.65 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

259,134

Previous 238,937 8.45%

Holding current value

$6.65 Million

Previous $6.69 Million 12.18%

% of portfolio

1.91%

Previous 1.82%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$27.7 - $31.39 $559,456 - $633,983	20,197 Added 8.45%	259,134 $7.5 Million
Q2 2024 Aug 15, 2024	BUY	$25.26 - $29.6 $2.08 Million - $2.44 Million	82,497 Added 52.73%	238,937 $6.69 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $587,521 - $674,662	22,693 Added 16.97%	156,440 $4.34 Million
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $49,228 - $63,942	1,884 Added 1.43%	133,747 $3.85 Million
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $170,879 - $199,740	5,325 Added 4.21%	131,863 $4.37 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $39,587 - $45,801	-1,096 Reduced 0.86%	126,538 $4.64 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $27,573 - $35,896	-700 Reduced 0.55%	127,634 $5.21 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $88,969 - $116,139	2,131 Added 1.69%	128,334 $0
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $311,746 - $380,564	-7,124 Reduced 5.34%	126,203 $5.52 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $61,047 - $72,383	1,312 Added 0.99%	133,327 $6.99 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $173,712 - $215,251	-3,797 Reduced 2.8%	132,015 $6.83 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $58,922 - $87,342	-1,426 Reduced 1.04%	135,812 $8.02 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $26,886 - $34,537	-685 Reduced 0.5%	137,238 $5.9 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $29,266 - $33,154	-815 Reduced 0.59%	137,923 $5.4 Million
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $8,339 - $9,404	-249 Reduced 0.18%	138,738 $5.03 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $33,570 - $42,687	-1,003 Reduced 0.72%	138,987 $5.12 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $143,795 - $168,705	-4,529 Reduced 3.13%	139,990 $5.14 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $16,686 - $20,243	554 Added 0.38%	144,519 $4.73 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $178,992 - $255,741	6,622 Added 4.82%	143,965 $4.7 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $41,709 - $47,335	1,267 Added 0.93%	137,343 $5.38 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $7,700 - $9,984	-237 Reduced 0.17%	136,076 $4.89 Million
Q2 2019 Aug 09, 2019	BUY	$36.98 - $41.52 $151,470 - $170,065	4,096 Added 3.1%	136,313 $5.91 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $21,112 - $23,195	-563 Reduced 0.42%	132,217 $5.62 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $293,679 - $334,827	-7,634 Reduced 5.44%	132,780 $5.8 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $123,023 - $149,219	3,569 Added 2.61%	140,414 $6.19 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $171,594 - $182,937	-5,203 Reduced 3.66%	136,845 $4.96 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $50,513 - $58,602	-1,583 Reduced 1.1%	142,048 $5.04 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $132,873 - $140,983	-3,995 Reduced 2.71%	143,631 $5.2 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $82,398 - $90,770	-2,658 Reduced 1.77%	147,626 $5.18 Million
Q2 2017 Aug 16, 2017	BUY	N/A	150,284	150,284 $5.02 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.

Account

Raab & Moskowitz Asset Management LLC Pfizer Inc Transaction History